Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development
Advanced Science · 2026
DOI: 10.1002/advs.202505249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jingyuan Tong und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Thrombocythemia, Essential, Hematopoietic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Essential thrombocythemia (ET) includes the JAK2 ‐, CALR ‐, and MPL ‐mutated subtypes, and a triple‐negative (TN) ET subtype, which lacks these canonical drivers. How specific driver mutations affect hematopoietic stem cell (HSC) heterogeneity and their relation to ET pathogenesis remain unclear. Here, by using single‐cell RNA sequencing (scRNA‐seq) combined with driver mutation detection across ET patients, it is found that MPL ‐mutated HSCs exhibited aberrant metabolism, CALR ‐mutated HSCs displayed active cell cycling, while JAK2 V617F ‐mutated HSCs demonstrated enhanced megakaryocyte (Mk) priming capacity and interferon (IFN) response. An HSC subset is identified in TN ET that transcriptionally resembled driver‐mutated HSCs, exhibiting enhanced megakaryocytic priming and proliferative activity. Notably, the frequency of a CXCR4 + HSC subset is reduced across the ET spectrum. Loss of CXCR4 + HSCs skewed lineage differentiation of HSCs toward the myeloid lineage, whereas restoring this subset delayed the onset of ET. Altogether, this study reveals both the shared and distinct molecular features of mutant HSCs in ET and provides novel insights into the pathogenesis and potential therapeutic strategies of ET.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
- Tianjin Institutes of Health Science, Tianjin, 301600, China.
ORCID-Profile: Lihong Shi
Förderung
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Clinical Research Fund of National Center for Clinical Medical Research of Hematology Diseases
- CAMS Innovation Fund for Medical Sciences
- Foundation of Tianjin Municipal Health Commission
- Special Research Fund for Central Universities, Peking Union Medical College
- Tianjin Municipal Science and Technology Commission Grant
Zitieren
APA
Tong, J., Wang, D., Song, H., Sun, T., Zhao, Y., Gu, W., Lin, L., Zhao, Y., Liang, Y., Jin, X., Fu, R., Ju, M., Gao, J., Ma, J., Gao, C., Zhang, A., Xiao, Z., Jiang, E., Yang, R., …, & Shi, L. (2026). Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development. Advanced Science. https://doi.org/10.1002/advs.202505249
Vancouver
Tong J, Wang D, Song H, Sun T, Zhao Y, Gu W, et al. Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development. Advanced Science. 2026. doi:10.1002/advs.202505249
BibTeX
@article{Tong2026,
author = {Tong, Jingyuan and Wang, Di and Song, Haoze and Sun, Ting and Zhao, Yanhong and Gu, Wenjing and Lin, Lexuan and Zhao, Yitong and Liang, Yipeng and Jin, Xu and Fu, Rongfeng and Ju, Mankai and Gao, Jie and Ma, Jinfa and Gao, Chengjie and Zhang, Anqi and Xiao, Zhijian and Jiang, Erlie and Yang, Renchi and Ma, Shihui and Zhang, Lei and Shi, Lihong},
title = {Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202505249}
}
EUVIMED